Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
D000804:Angiotensin II; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology*; D004791:Enzyme Inhibitors; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D009842:Oligopeptides / Q000494:pharmacology*; D007703:Peptidyl-Dipeptidase A; D011392:Proline / Q000031:analogs & derivatives*; D011945:Receptors, Angiotensin / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects; D012910:Snake Venoms / Q000494:pharmacology*; D013722:Teprotide / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D009842:Oligopeptides; D011945:Receptors, Angiotensin; D012910:Snake Venoms; D000804:Angiotensin II; D011392:Proline; D002216:Captopril; D013722:Teprotide; D007703:Peptidyl-Dipeptidase A